Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dermata Therapeutics, Inc. - Common Stock (NQ:DRMA)

1.630 +0.210 (+14.79%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 211,244
Open 1.430
Bid (Size) 1.570 (100)
Ask (Size) 1.610 (100)
Prev. Close 1.420
Today's Range 1.410 - 1.630
52wk Range 0.9509 - 6.225
Shares Outstanding 1,026,457
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Dermata Announces Preorders Now Open for Tome Foundational Treatment Ahead of Commercial Launch
From Dermata Therapeutics
Via ACCESS Newswire
News headline image
Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
From Dermata Therapeutics
Via ACCESS Newswire

Performance

YTD
-25.2%
-25.2%
1 Month
+23.5%
+23.5%
3 Month
+32.5%
+32.5%
6 Month
+27.3%
+27.3%
1 Year
-72.0%
-72.0%

More News

Read More
Unusual volume stocks are being observed in Wednesday's session. ↗
Via Chartmill
The market is filled with gapping stocks in Wednesday's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
Dermata Therapeutics (NASDAQ:DRMA) Q1 2026 Earnings: Narrowing Losses and Strategic Pivot to DTC Skincare ↗
Via Chartmill
News headline image
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026
From Dermata Therapeutics
Via ACCESS Newswire
News headline image
Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment
From Dermata Therapeutics
Via ACCESS Newswire
News headline image
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026
Via ACCESS Newswire
News headline image
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System
Via ACCESS Newswire
News headline image
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025
Via ACCESS Newswire
What's going on in today's session ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
Get insights into the top gainers and losers of Thursday's after-hours session. ↗
Via Chartmill
News headline image
Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing
Via ACCESS Newswire
News headline image
Dermata Opens a New Chapter with the Release of Tome Skincare
Via ACCESS Newswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Top movers in Friday's session ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
Which stocks are moving before the opening bell on Friday? ↗
Via Chartmill
Top stock movements in today's session. ↗
Via Chartmill
These stocks are moving in today's session ↗
Via Chartmill
Gapping stocks in Thursday's session ↗
Via Chartmill
Tuesday's after hours session: top gainers and losers ↗
Via Chartmill

Frequently Asked Questions

Is Dermata Therapeutics, Inc. - Common Stock publicly traded?
Yes, Dermata Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Dermata Therapeutics, Inc. - Common Stock trade on?
Dermata Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Dermata Therapeutics, Inc. - Common Stock?
The ticker symbol for Dermata Therapeutics, Inc. - Common Stock is DRMA on the Nasdaq Stock Market
What is the current price of Dermata Therapeutics, Inc. - Common Stock?
The current price of Dermata Therapeutics, Inc. - Common Stock is 1.630
When was Dermata Therapeutics, Inc. - Common Stock last traded?
The last trade of Dermata Therapeutics, Inc. - Common Stock was at 08/24/26 04:00 PM ET
What is the market capitalization of Dermata Therapeutics, Inc. - Common Stock?
The market capitalization of Dermata Therapeutics, Inc. - Common Stock is 1.67M
How many shares of Dermata Therapeutics, Inc. - Common Stock are outstanding?
Dermata Therapeutics, Inc. - Common Stock has 2M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.